- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.02.2026 | 1.331 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 18.02.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 18.02.2026ISIN NameDE000A31C3Y4 ALTECH... ► Artikel lesen | |
| 18.02. | XFRA Q3I: AUSSETZUNG/SUSPENSION | 230 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILADDVISE GROUP AB... ► Artikel lesen | |
| 16.02. | ADDvise Group AB (publ): Resolutions at the extraordinary general meeting in ADDvise Group AB (publ) | 441 | GlobeNewswire (Europe) | At the extraordinary general meeting in ADDvise Group AB (publ) ("ADDvise") held today on 16 February 2026, Mia Tomczak and Richard Jernberg were elected as new board members of the company. The resolution... ► Artikel lesen | |
| 12.02. | ADDvise Group AB (publ): Year-end report 2025, January 1-December 31 | 334 | GlobeNewswire (Europe) | Increased profits, profitability and stable cash flow. In the fourth quarter, organic sales increased by 4.0% in constant currency and an increase of 1.5% for the full year 2025. Our focus on operational... ► Artikel lesen | |
| 03.02. | ADDvise Group AB (publ): Delisting of the shares and warrants in ADDvise from Nasdaq First North | 288 | GlobeNewswire (Europe) | On 29 January 2026, ADDvise Group AB (publ) ("ADDvise") announced that its board of directors had applied for delisting of the shares and warrants in ADDvise from Nasdaq First North Premier Growth Market... ► Artikel lesen | |
| 29.01. | ADDvise Group AB (publ): ADDvise has applied for delisting of its shares and warrants from Nasdaq First North | 280 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex"), announced a public offer (the "Offer") to the holders of shares and warrants of ADDvise Group AB (publ) ("ADDvise"). On 27 January 2026, Amplex announced that... ► Artikel lesen | |
| ADDVISE GROUP Aktie jetzt für 0€ handeln | |||||
| 14.01. | ADDvise Group AB (publ): ADDvise announces financial update for 2025 | 269 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the holders of shares and warrants in ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all their... ► Artikel lesen | |
| 05.01. | ADDvise Group AB (publ): Statement from the independent bid committee of ADDvise in relation to the public offer from Amplex | 273 | GlobeNewswire (Europe) | The independent bid committee of ADDvise recommends that holders of shares and warrants who have a short-term perspective on their ownership or who do not wish to be owners in a listed ADDvise with... ► Artikel lesen | |
| 02.01. | ADDvise Group AB (publ): ADDvise initiates a written procedure under its outstanding bonds 2025/2028 in light of the public offer from Amplex | 503 | GlobeNewswire (Europe) | ADDvise Group AB (publ) (the "Company" or "ADDvise") has instructed the agent under the Company's outstanding bonds 2025/2028 with ISIN SE0025011885 (the "Bonds") to initiate a written procedure in... ► Artikel lesen | |
| 19.12.25 | ADDvise Group AB (publ): Amplex has increased the consideration in the public offer to the shareholders and warrant holders of ADDVise | 252 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all shares... ► Artikel lesen | |
| 10.12.25 | ADDvise Group AB (publ) receives observation status | 502 | GlobeNewswire | Today, December 10, 2025, Amplex AB disclosed a public offer to the other shareholders and equity rights holders of ADDvise Group AB (publ).
The rules of Nasdaq First North Growth Market state... ► Artikel lesen | |
| 10.12.25 | ADDvise Group AB (publ): ADDvise's board of directors evaluates the public offer from Amplex | 431 | GlobeNewswire (Europe) | Amplex AB ("Amplex") has today announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise") to transfer all shares and warrants in ADDvise to Amplex at a price... ► Artikel lesen | |
| 12.11.25 | ADDvise Group AB (publ): ADDvise receives order worth USD 2.3 million | 266 | GlobeNewswire (Europe) | ADDvise Group's subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3... ► Artikel lesen | |
| 23.10.25 | ADDvise Group AB (publ): Interim report 2025, January 1-September 30 | 268 | GlobeNewswire (Europe) | Strengthened profitability and cash flow despite a quarter with macro headwinds. In the third quarter, organic sales decreased by 4.8% in constant currency, but the year-to-date growth remains positive.... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 37,630 | +2,48 % | Fresenius Medical Care: Plötzlicher Führungswechsel schürt Zweifel an Zukunft - Kurs bricht weiter ein | Der überraschende Führungswechsel bei Fresenius Medical Care lässt die Aktie abstürzen und schürt Spekulationen über einen radikalen Kurswechsel im angeschlagenen Dialysegeschäft. Anleger und Analysten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,750 | +1,28 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers vor Zahlen zum vierten Geschäftsquartal auf "Hold" mit einem Kursziel von 39 Euro belassen. Er rechne... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,120 | +3,41 % | GOLDMAN SACHS stuft CARL ZEISS MEDITEC AG auf 'Sell' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat Carl Zeiss Meditec von "Neutral" auf "Sell" abgestuft und das Kursziel von 27 auf 23 Euro gesenkt. Analyst Richard Felton begründete... ► Artikel lesen | |
| INTUITIVE SURGICAL | 370,50 | -0,04 % | Intuitive Surgical: Bewertungsabschlag ohne Bruch der Investment-Story - Chance für geduldige Qualitätsanleger? | Intuitive Surgical bleibt operativ auf Kurs, während die Bewertung nachgibt. Trotz temporärer Belastungen durch Nachholeffekte aus der Pandemie und makroökonomische Unsicherheiten sieht Seeking Alpha... ► Artikel lesen | |
| UNITEDHEALTH | 329,00 | -0,54 % | UnitedHealth (NYSE:UNH): America's Health System Creates The Opportunity For The Largest Listed Health Care Company! | ||
| MEDTRONIC | 78,98 | +0,95 % | Zwei Dividendenwerte im Crash-Rabatt: Warum Cisco und Medtronic jetzt ins Visier konservativer Anleger rücken | Der jüngste Kursrückgang an den Aktienmärkten eröffnet nach Einschätzung eines Beitrags auf Seeking Alpha selektive Einstiegsgelegenheiten bei dividendenstarken Blue Chips. Im Fokus stehen Cisco Systems... ► Artikel lesen | |
| THERMO FISHER | 579,80 | -0,24 % | Thermo Fisher Scientific: Strategische Neuausrichtung und Margenwachstum! | ||
| TELADOC HEALTH | 5,034 | +1,99 % | Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform | ||
| HIMS & HERS HEALTH | 25,360 | +1,36 % | Truist reiterates Hold on Hims and Hers stock, $32 target | ||
| BICO GROUP | 2,035 | +3,51 % | BICO Group AB: BICO Completes Integration of Cellenion into SCIENION, Strengthening Precision Biotech Platform | BICO Group AB (publ) today announces the completion of the integration of Cellenion into SCIENION, bringing the businesses, technologies, and teams together under a single organization and brand.
This... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 76,60 | +1,51 % | Eurofins Scientific SE: Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (Paris:ERF) (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| BECTON DICKINSON | 162,00 | -0,55 % | BD (Becton, Dickinson and Company): BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results | Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 125,95 | +0,20 % | Align Technology hit as appeals court revives dental aligners antitrust claims | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| INMODE | 12,410 | -1,12 % | InMode Ltd.: InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 | YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen |
ADDVISE GROUP AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,142 Euro. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,00 Euro errechnet sich eine Dividendendrendite von 0,00 %.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADDVISE GROUP AB finden Sie auf Wallstreet Online.